About Biogen
Biogen Idec Austria GmbH was founded in 1997 as a subsidiary of the world's leading biotechnology company Biogen Idec Inc. The Austrian headquarters are located in Vienna. Biogen Idec's research focuses on neurology, immunology and oncology. In Austria, the focus is on research and development of products related to multiple sclerosis (MS). MS is the most common disease of the central nervous system in young adults. Our company plays a market-leading role in this field. Further research focuses on auto-immune diseases, such as psoriasis.
In everything we do, we apply our full potential. Patients are at the center of everything we do. We place particular emphasis on better understanding their needs so that we can further develop our products.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Biotechnology
